UNS 0.00% 0.5¢ unilife corporation

Who owns the IP?, page-11

  1. 41 Posts.
    From the Annual Report: We have one reporting unit which includes our product lines, the base technology which we obtained as part of our November 2002 acquisition of Unitract Syringe Pty Limited, and the manufacturing capability which we obtained in our January 2007 acquisition of Integrated BioSciences, Inc.​
 
watchlist Created with Sketch. Add UNS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.